EyePoint Pharmaceuticals | 8-K:重大事件
EyePoint Pharmaceuticals | 8-K:重大事件
EyePoint Pharmaceuticals | 8-K:重大事件
EyePoint Pharmaceuticals | 8-K:重大事件
EyePoint Pharmaceuticals | S-8:员工福利计划证券登记
EyePoint Pharmaceuticals | S-3:特定交易注册声明
EyePoint Pharmaceuticals | 8-K:EyePoint Pharmicals公布2024年第二季度财务业绩并重点介绍最近的公司发展
EyePoint Pharmaceuticals | 8-K:重大事件
EyePoint Pharmaceuticals | 8-K:重大事件
EyePoint Pharmaceuticals | 8-K:重大事件
EyePoint Pharmaceuticals | 8-K:EyePoint Pharmicals公布2024年第一季度财务业绩并重点介绍最近的公司发展
EyePoint Pharmaceuticals | 8-K:重大事件
EyePoint Pharmaceuticals | DEFA14A:其他
EyePoint Pharmaceuticals | DEF 14A:股东委托书决议
EyePoint Pharmaceuticals | 8-K:EyePoint Pharmaceuticals公布了2023年第四季度和全年财务业绩,并重点介绍了最近的公司发展
EyePoint Pharmaceuticals | 8-K:重大事件
EyePoint Pharmaceuticals | 8-K:重大事件
EyePoint Pharmaceuticals | 8-K:重大事件
EyePoint Pharmaceuticals | 8-K:重大事件
EyePoint Pharmaceuticals | 8-K:重大事件
暂无数据
暂无数据